Jazz Pharmaceuticals (JAZZ) News Today $122.72 +1.14 (+0.94%) (As of 11:27 AM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Jazz Pharmaceuticals to Present Advancements in Solid Tumors and Blood Cancer Research at San Antonio Breast Cancer Symposium and American Society of Hematology Annual MeetingDecember 3 at 7:49 AM | prnewswire.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Sees Significant Increase in Short InterestJazz Pharmaceuticals plc (NASDAQ:JAZZ - Get Free Report) saw a large increase in short interest in the month of November. As of November 15th, there was short interest totalling 3,820,000 shares, an increase of 6.4% from the October 31st total of 3,590,000 shares. Based on an average daily trading volume, of 707,100 shares, the days-to-cover ratio is currently 5.4 days. Approximately 6.6% of the shares of the company are short sold.December 3 at 6:01 AM | marketbeat.comPoint72 Asia Singapore Pte. Ltd. Buys 4,627 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Point72 Asia Singapore Pte. Ltd. grew its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 46.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 14,593 shares of the specialty pharmaceuticaDecember 2 at 6:19 AM | marketbeat.comARGA Investment Management LP Acquires 5,562 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)ARGA Investment Management LP lifted its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 83.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 12,195 shares of the specialty pharmaceutical comDecember 1 at 6:41 AM | marketbeat.comCerity Partners LLC Buys 18,414 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Cerity Partners LLC grew its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 128.4% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 32,757 shares of the specialty pharmaceutical company's stock afterNovember 30 at 3:37 AM | marketbeat.comCharles Schwab Investment Management Inc. Purchases 42,587 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Charles Schwab Investment Management Inc. grew its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 8.7% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 531,710 shares of the specialty pharmaceutical company'November 30 at 3:36 AM | marketbeat.comIntech Investment Management LLC Reduces Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Intech Investment Management LLC reduced its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 47.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,639 shares of the specialty pharmaceutical company'sNovember 30 at 3:26 AM | marketbeat.comThrivent Financial for Lutherans Lowers Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Thrivent Financial for Lutherans lowered its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 44.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 14,619 shares of the specialty phaNovember 30 at 3:15 AM | marketbeat.comVestal Point Capital LP Lowers Stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Vestal Point Capital LP lessened its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 40.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 900,000 shares of the specialty pharmaceutical comNovember 29, 2024 | marketbeat.comBridgewater Associates LP Has $12.59 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Bridgewater Associates LP grew its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 11.7% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 112,999 shares of the specialty pharmaceutical company'sNovember 29, 2024 | marketbeat.comJazz Pharmaceuticals Increases Commitments and Extends Maturity Date of Revolving Credit FacilityNovember 28, 2024 | americanbankingnews.comConnor Clark & Lunn Investment Management Ltd. Has $2.08 Million Stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Connor Clark & Lunn Investment Management Ltd. cut its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 21.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,633 shares of the specialty pharmNovember 26, 2024 | marketbeat.comJazz Pharmaceuticals (NASDAQ:JAZZ) Earns "Buy" Rating from HC WainwrightNovember 26, 2024 | americanbankingnews.comJazz Pharmaceuticals Receives FDA Accelerated Approval for Ziihera in HER2-Positive Biliary Tract CancerOn November 20, 2024, Jazz Pharmaceuticals plc (NASDAQ: JAZZ) announced the U.S. Food and Drug Administration's accelerated approval of Ziihera (zNovember 25, 2024 | americanbankingnews.comJazz Pharmaceuticals' (JAZZ) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright restated a "buy" rating and issued a $200.00 price objective on shares of Jazz Pharmaceuticals in a report on Friday.November 22, 2024 | marketbeat.comValence8 US LP Invests $999,000 in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Valence8 US LP bought a new position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 8,969 shares of the specialty pharmaceutical company's stock, valued at approNovember 22, 2024 | marketbeat.comBNP PARIBAS ASSET MANAGEMENT Holding S.A. Reduces Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)BNP PARIBAS ASSET MANAGEMENT Holding S.A. reduced its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 2.1% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 429,077 shares of the specialty pharmaceutical company's stock after selling 9,134 sharNovember 22, 2024 | marketbeat.comFDA grants accelerated approval to Jazz Pharmaceuticals’ ZiiheraNovember 22, 2024 | markets.businessinsider.comJazz Pharmaceuticals price target lowered to $163 from $166 at Piper SandlerNovember 21, 2024 | markets.businessinsider.comZymeworks Shares Rise 8.3% After Licensed Cancer Treatment Gets FDA OKNovember 21, 2024 | marketwatch.comBiotech Stock Roundup: SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval & MoreNovember 21, 2024 | msn.comFDA Greenlights Jazz Pharma's Cancer Drug, A Milestone For ZymeworkNovember 21, 2024 | benzinga.comJazz and Zymeworks announce FDA approval of cancer therapy ZiiheraNovember 21, 2024 | seekingalpha.comPositive Outlook for Jazz Pharmaceuticals Following Ziihera ApprovalNovember 21, 2024 | markets.businessinsider.comJazz Pharmaceuticals: Promising Growth Potential with Robust Pipeline and Undervalued Market PositionNovember 21, 2024 | markets.businessinsider.comPacer Advisors Inc. Buys 278,465 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Pacer Advisors Inc. raised its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 15.3% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 2,099,378 shares of the specialty pharmaceutical company's stock after purchasing an additional 27November 21, 2024 | marketbeat.comThompson Siegel & Walmsley LLC Increases Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Thompson Siegel & Walmsley LLC increased its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 8.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 781,215 shares of the specialty pharmaceutical company's stocNovember 21, 2024 | marketbeat.comJohn G Ullman & Associates Inc. Sells 11,400 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)John G Ullman & Associates Inc. lowered its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 20.2% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 45,094 shares of the specialNovember 21, 2024 | marketbeat.comJazz Pharma Gains FDA Accelerated Approval For Ziihera To Treat HER2-positive Biliary Tract CancerNovember 21, 2024 | markets.businessinsider.comJazz Pharmaceuticals receives FDA approval for biliary tract cancer treatmentNovember 20, 2024 | reuters.comJazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)November 20, 2024 | prnewswire.comJazz Pharmaceuticals to Participate in Citi's 2024 Global Healthcare ConferenceNovember 19, 2024 | prnewswire.comSilver Ring Value Partners: Jazz Pharmaceuticals (JAZZ) Is a “High Uncertainty With Low Risk” InvestmentNovember 19, 2024 | uk.finance.yahoo.comSilver Ring Value Partners Q3 2024 LetterNovember 18, 2024 | seekingalpha.comIs Jazz Pharmaceuticals plc (JAZZ) the Best Immunotherapy Stock to Buy Now?November 18, 2024 | msn.comJazz Pharmaceuticals: High Uncertainty, Low RiskNovember 18, 2024 | seekingalpha.comJazz Pharmaceuticals price target raised to $162 from $154 at BairdNovember 18, 2024 | markets.businessinsider.comJazz Pharmaceuticals (NASDAQ:JAZZ) Given New $162.00 Price Target at Robert W. BairdRobert W. Baird raised their target price on shares of Jazz Pharmaceuticals from $154.00 to $162.00 and gave the company an "outperform" rating in a research report on Monday.November 18, 2024 | marketbeat.comVictory Capital Management Inc. Increases Stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Victory Capital Management Inc. boosted its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 23.3% during the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 253,299 shares of the specialty pharmaceutical company's stock after buyinNovember 18, 2024 | marketbeat.comLos Angeles Capital Management LLC Makes New Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Los Angeles Capital Management LLC purchased a new position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 5,606 shares of the specialty pharmaceutical compaNovember 17, 2024 | marketbeat.comKBC Group NV Has $25.44 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)KBC Group NV decreased its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 39.6% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 228,304 shares of the specialty pharmaceutical company's stock after selNovember 16, 2024 | marketbeat.comPrincipal Financial Group Inc. Trims Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Principal Financial Group Inc. lowered its holdings in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 31.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 142,938 shares of the speciaNovember 16, 2024 | marketbeat.comJazz Pharmaceuticals' (NASDAQ:JAZZ) Performance Is Even Better Than Its Earnings SuggestNovember 15, 2024 | finance.yahoo.comNeena M Patil Executes Sell Order: Offloads $456K In Jazz Pharmaceuticals StockNovember 15, 2024 | benzinga.comInsider Selling: Jazz Pharmaceuticals plc (NASDAQ:JAZZ) EVP Sells 3,700 Shares of StockNovember 14, 2024 | insidertrades.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Given Average Recommendation of "Moderate Buy" by AnalystsJazz Pharmaceuticals plc (NASDAQ:JAZZ - Get Free Report) has been given an average rating of "Moderate Buy" by the fifteen brokerages that are currently covering the company, MarketBeat reports. Three analysts have rated the stock with a hold rating and twelve have given a buy rating to the companNovember 14, 2024 | marketbeat.comBaupost's top Q3 trades include Jazz exit, new Dollar General stakeNovember 13, 2024 | msn.comKovack Advisors Inc. Has $6.43 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Kovack Advisors Inc. boosted its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 20.4% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 57,672 shares of the specialty pharmaNovember 13, 2024 | marketbeat.comAmerican Assets Inc. Purchases New Stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)American Assets Inc. bought a new position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 5,000 shares of the specialty pharmaceutical company's sNovember 12, 2024 | marketbeat.comBarclays Reaffirms Their Hold Rating on Pacira Pharmaceuticals (PCRX)November 12, 2024 | markets.businessinsider.com Get Jazz Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for JAZZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Is the Trump/Musk duo good for shares of TSLA? (Ad)If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla. Discover how to trade Tesla, simply follow this link here. JAZZ Media Mentions By Week JAZZ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. JAZZ News Sentiment▼1.250.87▲Average Medical News Sentiment JAZZ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. JAZZ Articles This Week▼129▲JAZZ Articles Average Week Get Jazz Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for JAZZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RPRX News CORT News PRGO News SUPN News PCRX News OMER News NKTR News ASMB News CPIX News LLY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:JAZZ) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jazz Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Jazz Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
